Technical Analysis for GLAXF - GlaxoSmithKline Plc

Grade Last Price % Change Price Change
B 18.1082 0.32% 0.0582
GLAXF closed up 0.32 percent on Monday, April 12, 2021, on 0 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical GLAXF trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Bollinger Band Squeeze Range Contraction 0.32%
Narrow Range Bar Range Contraction 0.32%
Gapped Up Strength 0.32%
Pocket Pivot Bullish Swing Setup 0.66%
Bollinger Band Squeeze Range Contraction 0.66%
Older End-of-Day Signals for GLAXF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


GlaxoSmithKline Plc Description

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology; and strategic alliance with Merck KGaA to jointly develop and commercialize M7824 (bintrafusp alfa), an investigational bifunctional fusion protein immunotherapy. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Pharmaceutical Industry Pharmaceutical Industry In China Pharmaceutical Products Pharmacology Healthcare Products Inflammation Breath Infant Vaccines Asthma Immunotherapy Paste Dermatology A Therapeutic Malt Alfa Syrup Hiv Consumer Healthcare Merck Rare Diseases Cleanser Urinary Tract Infection Nasal Spray Sbi Quell Thk Urinary Tract Infections Mouthwash Rare Disease Toothpaste Glaxosmithkline Consumer Healthcare Products Dermal Patch Decongestants Diclofenac Lamisil

Is GLAXF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 22.0
52 Week Low 16.5
Average Volume 473,387
200-Day Moving Average 18.7567
50-Day Moving Average 17.5450
20-Day Moving Average 17.8404
10-Day Moving Average 17.8726
Average True Range 0.3989
ADX 7.89
+DI 21.5221
-DI 24.9772
Chandelier Exit (Long, 3 ATRs ) 17.1733
Chandelier Exit (Short, 3 ATRs ) 18.1967
Upper Bollinger Band 18.2234
Lower Bollinger Band 17.4574
Percent B (%b) 0.85
BandWidth 4.2936
MACD Line 0.1227
MACD Signal Line 0.0889
MACD Histogram 0.0337
Fundamentals Value
Market Cap 90.86 Billion
Num Shares 5.02 Billion
EPS 0.50
Price-to-Earnings (P/E) Ratio 36.51
Price-to-Sales 2.00
Price-to-Book 4.77
PEG Ratio 10.88
Dividend 1.00
Dividend Yield 5.52%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.4955
Resistance 3 (R3) 18.4525 18.2803 18.4310
Resistance 2 (R2) 18.2803 18.1817 18.3019 18.4094
Resistance 1 (R1) 18.1943 18.1208 18.2373 18.2373 18.3879
Pivot Point 18.0221 18.0221 18.0437 18.0437 18.0221
Support 1 (S1) 17.9361 17.9235 17.9791 17.9791 17.8285
Support 2 (S2) 17.7639 17.8626 17.7855 17.8070
Support 3 (S3) 17.6779 17.7639 17.7855
Support 4 (S4) 17.7209